HIGHFDA DRUG

Zydus Chlorpromazine Hydrochloride 200 mg Recall Expands Nationwide Over CGMP Deviations

The FDA confirms a nationwide recall of Zydus Lifesciences Chlorpromazine Hydrochloride tablets 200 mg (NDC 70710-1133-1) distributed by Zydus Pharmaceuticals USA. The recall cites CGMP deviations and the presence of N-Nitroso Desmethyl Chlorpromazine above acceptable intake. Consumers and healthcare providers should stop using the product immediately and contact the distributor for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 3, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 3, 2025
Hazard Level
HIGH
Brands
Chlorpromazine Hydrochloride, Zydus Pharmaceuticals, Zydus Lifesciences
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, ELDERLY

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Chlorpromazine Hydrochloride, Zydus Pharmaceuticals, Zydus Lifesciences
Product type
Chlorpromazine Hydrochloride Tablets (200 mg)
Model numbers
Z305083, Z305084, Z305468, Z305469, Z305470, Z401163, Z401165, Z402217 +4 more
UPC codes
70710-1129, 70710-1130, 70710-1131, 70710-1132, 70710-1133, 70710-1129-1, 70710-1129-2, 70710-1129-4 +7 more
Sizes
200 mg
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 3, 2025

  2. Reported by FDA DRUG

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used to treat manic depression and schizophrenia symptoms.

Why This Is Dangerous

The impurity N-Nitroso Desmethyl Chlorpromazine above acceptable intake could pose health risks; CGMP deviations indicate manufacturing quality concerns.

Industry Context

This recall is not part of a broader pattern in the industry.

Real-World Impact

No injuries reported yet. The recall focuses on product safety and potential long-term health risks.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 70710-1133-1 on the bottle
  2. Check lot numbers if provided
  3. Confirm packaging shows Zydus Lifesciences or Zydus Pharmaceuticals logos

Where to find product info

FDA recall page and manufacturer contact; packaging details on label

What timeline to expect

No timeline provided; monitor FDA updates

If the manufacturer is unresponsive

  • Document all contact attempts
  • File a consumer complaint with FDA MedWatch if supplier unresponsive
  • Consult healthcare provider for alternatives

How to prevent similar issues

  • Verify NDC before dispensing to patients
  • Follow CGMP compliance updates for suppliers
  • Ask for documentation of manufacturing standards when sourcing drugs

Documentation advice

Keep bottle, packaging, recall notice, and correspondence with supplier

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Chlorpromazine Hydrochloride. Manufacturer: Zydus Lifesciences Ltd., Baddi, India. Distributor: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1133-1. Quantity and packaging: 100-count bottle. Sold nationwide in the USA. Recall date: 2025-09-03. Status: Active.

Reported Incidents

No specific consumer injuries or incidents are reported in the notice.

Key Facts

  • Manufactured by Zydus Lifesciences Ltd. (Baddi, India)
  • Distributed by Zydus Pharmaceuticals (USA) Inc. (Pennington, NJ)
  • Class II recall

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTELDERLYPREGNANT
Injury Types
POISONINGOTHER

Product Details

Model Numbers
Z305083
Z305084
Z305468
Z305469
Z305470
+7 more
UPC Codes
70710-1129
70710-1130
70710-1131
+12 more
Affected States
ALL
Report Date
September 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Zydus Pharmaceuticals Recalls Icosapent Ethyl Capsules Over Subpotency

Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients.

Zydus Pharmaceuticals
Subpotent Drug:
Read more